Recent Finacing
Recent Raise
Orphazyme is a Copenhagen-based biopharmaceutical company developing Orph-001, a recombinant human HSP70 therapy for lysosomal storage diseases, advancing it toward clinical development with academic collaborations.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Orphazyme.
